vimarsana.com

Latest Breaking News On - Livija deban - Page 1 : vimarsana.com

Prokarium Strengthens Patent Position Through Notice of Allowance of US Patent for Immunotherapy Prime in Combination with Cell Therapies

Prokarium Ltd ('Prokarium' or the 'Company'), a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, today announced the receipt of a Notice of Allowance from the United

United statesUnited kingdomCity ofKristen albrightKostenloser wertpapierhandelLisa stoneLivija debanTrademark officeProkarium ltdUnited states patentChief scientific officerChief executive officer

Prokarium Exercises Option for an Exclusive Worldwide License for the Use of Salmonella Immunotherapy in the Treatment of Bladder Cancer

Prokarium, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, announced today it exercised its option with Lausanne University Hospital (Centre Hospitalier Universitaire

United kingdomCity ofPatrice jichlinskiIlaria luccaMatthew corcoranLivija debanKristen albrightKostenloser wertpapierhandelDenise nardelli haefligerSonia domingos pereiraMedicine of the university lausanneHead of the urology research unitSwiss federal institute of technologyLausanne university hospital centre hospitalier universitaire vaudoisDepartment of urologyLausanne university hospital

Prokarium Promotes Livija Deban to Chief Scientific Officer to Drive Pipeline Expansion in Cancer Immunotherapy

Prokarium, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, today announced the appointment of Livija Deban, PhD, as Chief Scientific Officer. This press release

United kingdomCity ofKristen albrightMario brkuljOxford biotherapeuticsKostenloser wertpapierhandelLivija debanKing college londonUniversity vitaCancer research united kingdomUniversity of bolognaChief scientificChief scientific officerBusiness wireChief executive officerVice president

vimarsana © 2020. All Rights Reserved.